Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This is multicenter, randomised, placebo controlled, parallel, blinded (double-blind for
ozenoxacin versus placebo comparison and investigator blinded for retapamulin versus placebo
comparison), superiority clinical study comparing ozenoxacin cream versus placebo and
retapamulin ointment vs placebo, in patients with a clinical diagnosis of non-bullous or
bullous impetigo.